BSE Live
Mar 14, 16:00Prev. Close
396.55
Open Price
395.10
Bid Price (Qty.)
395.00 (1000)
Offer Price (Qty.)
396.55 (187)
NSE Live
Dec 27, 11:22Prev. Close
-
Open Price
-
Bid Price (Qty.)
- (0)
Offer Price (Qty.)
- (0)
| Balance Sheet of Claris Lifesciences (in Rs. Cr.) | Mar 17 | Mar 16 | Mar 15 | Dec 13 | Dec 12 | |
| 12 mths | 12 mths | 15 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 54.57 | 54.57 | 54.57 | 63.82 | 63.82 | |
| Total Share Capital | 54.57 | 54.57 | 54.57 | 63.82 | 63.82 | |
| Reserves and Surplus | 685.71 | 783.11 | 803.00 | 886.31 | 872.39 | |
| Total Reserves and Surplus | 685.71 | 783.11 | 803.00 | 886.31 | 872.39 | |
| Total Shareholders Funds | 740.28 | 837.68 | 857.57 | 950.13 | 936.21 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 16.58 | 11.89 | 14.32 | 126.83 | 298.95 | |
| Deferred Tax Liabilities [Net] | 0.00 | 2.34 | 2.73 | 58.97 | 71.67 | |
| Other Long Term Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 1.34 | |
| Long Term Provisions | 5.09 | 3.77 | 2.51 | 5.91 | 8.81 | |
| Total Non-Current Liabilities | 21.67 | 18.00 | 19.55 | 191.71 | 380.76 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 0.00 | 0.00 | 22.66 | 105.47 | 200.38 | |
| Trade Payables | 60.77 | 120.25 | 95.64 | 103.17 | 112.58 | |
| Other Current Liabilities | 114.98 | 108.75 | 268.77 | 292.82 | 154.71 | |
| Short Term Provisions | 0.31 | 16.49 | 4.61 | 90.10 | 19.66 | |
| Total Current Liabilities | 176.05 | 245.48 | 391.67 | 591.56 | 487.33 | |
| Total Capital And Liabilities | 938.00 | 1,101.16 | 1,268.79 | 1,733.40 | 1,804.30 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 49.35 | 55.10 | 36.86 | 503.16 | 804.74 | |
| Intangible Assets | 0.67 | 1.07 | 1.47 | 1.97 | 0.00 | |
| Capital Work-In-Progress | 2.40 | 6.06 | 1.77 | 173.29 | 174.27 | |
| Other Assets | 1.77 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Fixed Assets | 54.18 | 62.23 | 40.10 | 678.42 | 979.01 | |
| Non-Current Investments | 43.07 | 514.12 | 19.27 | 18.61 | 16.66 | |
| Deferred Tax Assets [Net] | 23.56 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Loans And Advances | 0.00 | 17.46 | 8.88 | 95.10 | 199.04 | |
| Other Non-Current Assets | 17.77 | 0.00 | 0.00 | 0.00 | 1.26 | |
| Total Non-Current Assets | 138.58 | 593.81 | 68.25 | 792.13 | 1,195.97 | |
| CURRENT ASSETS | ||||||
| Current Investments | 187.23 | 177.03 | 331.61 | 608.82 | 0.00 | |
| Inventories | 0.00 | 0.00 | 0.00 | 39.25 | 171.95 | |
| Trade Receivables | 22.96 | 127.43 | 151.85 | 154.79 | 247.94 | |
| Cash And Cash Equivalents | 22.23 | 45.26 | 44.24 | 89.13 | 113.34 | |
| Short Term Loans And Advances | 495.72 | 87.57 | 110.70 | 37.65 | 73.42 | |
| OtherCurrentAssets | 71.28 | 70.07 | 562.14 | 11.63 | 1.69 | |
| Total Current Assets | 799.42 | 507.35 | 1,200.55 | 941.27 | 608.33 | |
| Total Assets | 938.00 | 1,101.16 | 1,268.79 | 1,733.40 | 1,804.30 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 642.44 | 1,004.11 | 800.16 | 368.09 | 291.41 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 0.00 | 0.00 | 31.40 | 84.28 | 84.22 | |
| Stores, Spares And Loose Tools | 0.00 | 0.23 | 97.87 | 0.84 | 4.64 | |
| Trade/Other Goods | 0.00 | 0.23 | 97.87 | 0.84 | 4.64 | |
| Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 141.51 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 10.27 | 14.76 | 59.14 | 39.70 | 25.58 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | -- | -- | 19.61 | 3.77 | 3.13 | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | -- | 461.69 | 604.54 | 353.54 | 337.88 | |
| Other Earnings | 7.29 | -- | 11.58 | 2.90 | 2.15 | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | 34.18 | 34.18 | 34.18 | 39.98 | 39.98 | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Non-Current Investments Unquoted Book Value | 43.07 | 514.12 | 19.27 | 18.61 | 16.66 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | 134.25 | 42.25 | 63.93 | 82.63 | -- | |
| Current Investments Unquoted Book Value | 53.43 | 136.41 | 93.07 | 361.16 | -- |
03.12.2017
17.10.2017
31.07.2017
US FDA conducts surprise audit at Claris Life's Ahmedabad unit
27.07.2017
Claris completes injectables biz sale, to inform about transfer to shareholders by Oct